Bandingkan Harga & Kinerja Danasupra Erapacific Tbk. (DEFI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Danasupra Erapacific Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Danasupra Erapacific Tbk. diperdagangkan di Rp106 (kapitalisasi pasar 72,85 M, volume 24 jam 48,16 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Danasupra Erapacific Tbk., dan Danasupra Erapacific Tbk. lebih aktif diperdagangkan (48,16 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DEFI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 72,85 M | 167,37 M |
Volume | 48,16 jt | 71 rb |
Lot | 481,58 rb | 710 |
Perputaran | 5,24 M | 17,51 jt |
Harga Rata-rata | 108,75 | 246,63 |
Nilai Transaksi | 5,24 M | 17,51 jt |
Harga Ekuilibrium Indikatif | 106 | 246 |
Volume Ekuilibrium Indikatif | 2,16 rb | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Danasupra Erapacific Tbk.
Danasupra Erapacific Tbk PT. (The "Company") was established by notarial act Elliza, SH. no 65 dated 11 November 1994. Articles of the company has been approved by the Ministry of Justice of the Republic of Indonesia in its Decision Letter. C2-1.101.HT.01.01.Th.95 dated January 25, 1995. Based on the Notary Act Refizal, SH. 12, dated January 18, 2000 the company made changes to the status of the company closed to open company, authorized capital, change in nominal value of shares and public offering through the stock market. Articles of Association was approved by the Minister of Law and Legislation of the Republic of Indonesia in its Decision Letter. C-1248.HT.01.04.Th.2000 dated February 3, 2000.Accordance with Article 3 Articles of Association, the scope of its business is run financing activities which include consumer finance, factoring and leasing.
Selengkapnya di halaman DEFI →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
